{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:45:56Z","timestamp":1761093956371,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma &amp; Immunology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.anai.2021.05.022","type":"journal-article","created":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T12:28:06Z","timestamp":1621945686000},"page":"456-461","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Enabling antibiotic allergy evaluations and reintroduction of first-line antibiotics for patients with cystic fibrosis"],"prefix":"10.1016","volume":"127","author":[{"given":"Karen M.","family":"Anstey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Ellen","family":"Kleinhenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris M.","family":"Otani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.anai.2021.05.022_bib0001","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1016\/j.jaip.2020.06.060","article-title":"Antibiotic adverse reactions in adult cystic fibrosis patients","volume":"8","author":"Anstey","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.anai.2021.05.022_bib0002","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1378\/chest.106.4.1124","article-title":"Allergic reactions to parenteral beta-lactam antibiotics in patients with cystic fibrosis","volume":"106","author":"Pleasants","year":"1994","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.anai.2021.05.022_bib0003","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jcf.2006.11.001","article-title":"Beta-lactam allergy in adults with cystic fibrosis","volume":"6","author":"Burrows","year":"2007","journal-title":"J Cyst Fibros"},{"year":"2018","series-title":"Foundation Patient Registry, annual data report 2017","key":"10.1016\/j.anai.2021.05.022_bib0004"},{"issue":"1","key":"10.1016\/j.anai.2021.05.022_bib0005","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1385\/CRIAI:23:1:123","article-title":"Antibiotic hypersensitivity in patients with CF","volume":"23","author":"Ramesh","year":"2002","journal-title":"Clin Rev Allerg Immunol"},{"issue":"4","key":"10.1016\/j.anai.2021.05.022_bib0006","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/pai.13206","article-title":"The diagnosis of hypersensitivity to antibiotics is rarely confirmed by allergy work-up in cystic fibrosis patients","volume":"31","author":"Braun","year":"2020","journal-title":"Pediatr Allergy Immunol"},{"issue":"6","key":"10.1016\/j.anai.2021.05.022_bib0007","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jaip.2014.08.001","article-title":"Safety and outcomes of test doses for the evaluation of adverse drug reactions: a 5-year retrospective review","volume":"2","author":"Ianmatteo","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.anai.2021.05.022_bib0008","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.anai.2010.08.002","article-title":"Drug allergy: an updated practice parameter","volume":"105","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.anai.2021.05.022_bib0009","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.anai.2016.07.039","article-title":"Approach to the evaluation of adverse antibiotic reactions in patients with cystic fibrosis","volume":"117","author":"Petroni","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.anai.2021.05.022_bib0010","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.jaip.2016.09.045","article-title":"A proactive approach to penicillin allergy testing in hospitalized patients","volume":"5","author":"Chen","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"7","key":"10.1016\/j.anai.2021.05.022_bib0011","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/j.jaip.2019.03.025","article-title":"Safety, efficacy, and clinical impact of penicillin skin testing in immunocompromised cancer patients","volume":"7","author":"Taremi","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.anai.2021.05.022_bib0012","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.anai.2020.03.013","article-title":"Preoperative penicillin allergy testing in patients undergoing cardiac surgery","volume":"124","author":"Plager","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"12","key":"10.1016\/j.anai.2021.05.022_bib0013","doi-asserted-by":"crossref","first-page":"ofy306","DOI":"10.1093\/ofid\/ofy306","article-title":"The safety and efficacy of an oral penicillin challenge program in cancer patients: a multicenter pilot study","volume":"5","author":"Trubiano","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.anai.2021.05.022_bib0014","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1016\/j.jaip.2021.01.023","article-title":"Implementing a penicillin allergy delabeling service for the obstetric population","volume":"9","author":"Zhang","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.anai.2021.05.022_bib0015","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1001\/jama.2018.19283","article-title":"Evaluation and management of penicillin allergy: a review","volume":"321","author":"Shenoy","year":"2019","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.anai.2021.05.022_bib0016","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jaip.2018.04.042","article-title":"Long-term follow-up after penicillin allergy delabeling in ambulatory patients","volume":"7","author":"Lachover-Ruth","year":"2019","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["Annals of Allergy, Asthma &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120621004129?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120621004129?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:27:09Z","timestamp":1761053229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120621004129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S1081120621004129"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2021.05.022","relation":{},"ISSN":["1081-1206"],"issn-type":[{"type":"print","value":"1081-1206"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enabling antibiotic allergy evaluations and reintroduction of first-line antibiotics for patients with cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2021.05.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}